Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $113.76 billion. The enterprise value is $103.79 billion.
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 256.80 million shares outstanding. The number of shares has decreased by -1.20% in one year.
| Current Share Class | 256.80M |
| Shares Outstanding | 256.80M |
| Shares Change (YoY) | -1.20% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 96.30% |
| Float | 256.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.55 |
| PS Ratio | 10.26 |
| Forward PS | 9.07 |
| PB Ratio | 6.89 |
| P/TBV Ratio | 7.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.35 |
| EV / EBITDA | 22.64 |
| EV / EBIT | 23.55 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.65 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | n/a |
| Interest Coverage | 189.98 |
Financial Efficiency
Return on equity (ROE) is -5.64% and return on invested capital (ROIC) is 14.73%.
| Return on Equity (ROE) | -5.64% |
| Return on Assets (ROA) | 11.77% |
| Return on Invested Capital (ROIC) | 14.73% |
| Return on Capital Employed (ROCE) | 23.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.47 |
| Inventory Turnover | 4.79 |
Taxes
In the past 12 months, VRTX has paid $688.70 million in taxes.
| Income Tax | 688.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.06% in the last 52 weeks. The beta is 0.42, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -8.06% |
| 50-Day Moving Average | 461.71 |
| 200-Day Moving Average | 465.31 |
| Relative Strength Index (RSI) | 43.59 |
| Average Volume (20 Days) | 1,323,804 |
Short Selling Information
The latest short interest is 4.41 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 4.41M |
| Short Previous Month | 4.82M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 2.07 |
Income Statement
In the last 12 months, VRTX had revenue of $11.10 billion and -$988.90 million in losses. Loss per share was -$3.84.
| Revenue | 11.10B |
| Gross Profit | 5.89B |
| Operating Income | 4.41B |
| Pretax Income | n/a |
| Net Income | -988.90M |
| EBITDA | 4.58B |
| EBIT | 4.41B |
| Loss Per Share | -$3.84 |
Full Income StatementBalance Sheet
The company has $6.20 billion in cash and $1.65 billion in debt, giving a net cash position of $9.71 billion or $37.81 per share.
| Cash & Cash Equivalents | 6.20B |
| Total Debt | 1.65B |
| Net Cash | 9.71B |
| Net Cash Per Share | $37.81 |
| Equity (Book Value) | 16.50B |
| Book Value Per Share | 64.20 |
| Working Capital | 6.23B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$980.30 million and capital expenditures -$270.00 million, giving a free cash flow of -$1.25 billion.
| Operating Cash Flow | -980.30M |
| Capital Expenditures | -270.00M |
| Free Cash Flow | -1.25B |
| FCF Per Share | -$4.87 |
Full Cash Flow StatementMargins
Gross margin is 53.09%, with operating and profit margins of 39.71% and -8.91%.
| Gross Margin | 53.09% |
| Operating Margin | 39.71% |
| Pretax Margin | -2.70% |
| Profit Margin | -8.91% |
| EBITDA Margin | 41.30% |
| EBIT Margin | 39.71% |
| FCF Margin | n/a |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.20% |
| Shareholder Yield | 1.20% |
| Earnings Yield | -0.87% |
| FCF Yield | -1.10% |
Dividend DetailsAnalyst Forecast
The average price target for VRTX is $510.65, which is 15.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $510.65 |
| Price Target Difference | 15.27% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 10.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 13.24 and a Piotroski F-Score of 2.
| Altman Z-Score | 13.24 |
| Piotroski F-Score | 2 |